PRF Technologies (PRFX) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2025)
PRF Technologies (PRFX) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.84% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -11.73% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 7.65% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.86% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 27.15% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -6.48% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 11.32% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.90% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 28.35% |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | -11.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.99% |
| Jun 30, 2025 | -21.62% |
| Dec 31, 2024 | -12.92% |
| Jun 30, 2024 | 20.51% |
| Mar 31, 2024 | 23.06% |
| Dec 31, 2023 | 21.64% |